Correction: Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers

Affiliations

¹ Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Tokyo 108-8639, Japan.
² Laboratory of DNA Information Analysis, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
³ Department of Gastroenterology and Metabolism, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan.
⁴ Department of Anatomical Pathology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734- 8551, Japan.
⁵ Second Department of Surgery, Wakayama Medical University, Wakayama 641-8510, Japan.
⁶ Department of Gastroenterological Surgery, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
⁷ Department of Surgery, Osaka International Cancer Institute, Osaka 537-8511, Japan.
⁸ Department of Gastroenterological Surgery, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan.

Published Erratum

Mayuko Furuta et al. Oncotarget. 2018.

. 2018 Aug 3;9(60):31789.

doi: 10.18632/oncotarget.25960.

¹ Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Tokyo 108-8639, Japan.
² Laboratory of DNA Information Analysis, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
³ Department of Gastroenterology and Metabolism, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan.
⁴ Department of Anatomical Pathology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734- 8551, Japan.
⁵ Second Department of Surgery, Wakayama Medical University, Wakayama 641-8510, Japan.
⁶ Department of Gastroenterological Surgery, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
⁷ Department of Surgery, Osaka International Cancer Institute, Osaka 537-8511, Japan.
⁸ Department of Gastroenterological Surgery, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.25308.].

Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers.
Furuta M, Tanaka H, Shiraishi Y, Unida T, Imamura M, Fujimoto A, Fujita M, Sasaki-Oku A, Maejima K, Nakano K, Kawakami Y, Arihiro K, Aikata H, Ueno M, Hayami S, Ariizumi SI, Yamamoto M, Gotoh K, Ohdan H, Yamaue H, Miyano S, Chayama K, Nakagawa H. Furuta M, et al. Oncotarget. 2018 May 18;9(38):25075-25088. doi: 10.18632/oncotarget.25308. eCollection 2018 May 18. Oncotarget. 2018. PMID: 29861854 Free PMC article.